Related Experiment Video
Updated: Jun 18, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Randomized clinical trials in colon cancer
Heather B Neuman1, Jason Park, Martin R Weiser
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, H1206, New York, NY 10065, USA. neuman@surgery.wisc.edu
Surgical Oncology Clinics of North America
|November 17, 2009
Summary
Surgery is key for colon cancer survival. Adjuvant chemotherapy, like fluorouracil (5-FU), improves outcomes for high-risk patients, with ongoing research in minimally invasive techniques and better treatments.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Cancer Research
Background:
- Colon cancer treatment relies heavily on surgical resection, achieving over 60% 5-year survival.
- Fluorouracil (5-FU)-based adjuvant chemotherapy is standard for high-risk patients, enhancing disease-free survival.
- Current research trends aim to reduce surgical invasiveness and refine adjuvant therapies.
Purpose of the Study:
- To review randomized controlled trials (RCTs) significantly influencing colon cancer clinical management in 2009.
- To highlight advancements in surgical approaches and adjuvant chemotherapy regimens.
Main Methods:
- Review of pivotal randomized controlled trials published or impactful in 2009.
- Analysis of studies focusing on surgical techniques, staging, and adjuvant chemotherapy.
Main Results:
- Surgical resection alone offers substantial survival benefits for colon cancer patients.
- Adjuvant chemotherapy, particularly 5-FU-based regimens, is crucial for improving outcomes in high-risk populations.
- Research is advancing minimally invasive surgery and optimizing adjuvant treatment strategies.
Conclusions:
- Surgical management remains the cornerstone of colon cancer treatment.
- Adjuvant chemotherapy is a vital component in improving survival rates for at-risk patients.
- Future directions emphasize less invasive surgical options and enhanced chemotherapeutic regimens.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...